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Objective. The study was conducted to assess the treatment outcome of different category retreatment cases with the aim of finding
out the important predictors of unfavorable outcomes.Methodology.This hospital based prospective cohort study was conducted in
three tuberculosis units (TUs) of west Midnapore (a district of Eastern India), covering mostly the tribal populated areas. Patients
who were registered for Category II antituberculosis treatment between 1st quarter of 2013 (Jan toMar) and 4th quarter of 2013 (Oct
to Dec) were considered as our study cohort and they were followed up till December 2014.The study was started with 177 patients
but ultimately ended with 165 patients. Results. Unfavorable outcome was observed among 24.8% patients. Among them mostly
51.2% were defaulter, 22% were failure case, and 26.8% died during treatment. Patients, who were minority by religion, were found
4 times more vulnerable for unfavorable outcome. Unfavorable outcome was found 7 times more common among retreatment
TB cases who remain sputum positive after completion of initiation phase of Category II treatment. Conclusion. Programmatic
approach should be specified to address the minority by religion population and to reduce the load of sputum positive cases after
completion of initiation phase treatment by tracking them.
1. Introduction
Tuberculosis (TB) remains a major cause of morbidity and
mortality worldwide, despite increased disease notification
rate, spreading of antitubercular programmes. It is also a soci-
ological, economical, and mental burden for a society. The
World Health Organization (WHO) estimates that one-third
of the population of the world is infectedwithMycobacterium
tuberculosis. Globally more than 9.8 million new cases of
active TB are notified annually and 2-3 million deaths occur
in every year [1, 2]. In 2011, 2.3 million new TB cases and
43000 retreatment pulmonary TB cases were notified in India
[3].
Patients, who fail, default, or relapse after completion of
standard first-line TB treatment and present for retreatment,
are grouped together as Category II cases by theWorldHealth
Organization (WHO). In India where individual drug sus-
ceptibility testing (DST) settings are not universally accessible
till now, there patients are often treated with a standard
retreatment regimen of first-line agents (a regimen that adds a
single drug to the standard initial TB treatment regimen) [4].
Retreatment case’s outcomes often are found poor as MDR-
TB, especially in patients with treatment failure or default
cases [5].
Inappropriate implementation of the Revised National
Tuberculosis Control Programme (RNTCP) causes precipi-
tation of MDR-TB cases in the community. In this situation,
India is not well equipped to prevent the propagation and
dissemination of MDR-TB cases. So a new reemerging threat
is slowly growing within the Indian population that may arise
as a big challenge in future. MDR-TB is a man-made phe-
nomenon; poor treatment, poor drugs, and poor adherence
lead to the development of MDR-TB [6].
The tribal populations of Eastern India are likely to live
in particular discrete hard to reach geographic areas with
their common cultural and socioreligious beliefs which are
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quite different from the general population. The tribes are an
underprivileged community and always remain away from
the light of civilization and often with poor access to the
health care system. These factors make a communication
barrier with all health care facilities and make them more
vulnerable to develop drug resistant TB.
Smear +ve and −ve previously treated pulmonary TB
cases are suspected as MDR-TB case according to Program-
matic Management of Drug Resistant TB (PMDT) guideline.
But in India where drug resistance TB diagnosis facilities are
not available widely till now, there unfavorable outcomes of
retreatment TB cases in the environment of poor RNTCP
covered area (tribal areas) can be suspected highly as the
source of drug resistant TB. Unfavourable outcome of retreat-
ment TB cases and poorly accessed health facility areas (tribal
area) both could be consider as common attributed factors for
drug resistant TB [6].
In Eastern India retreatment TB related research work
among tribal population is scarce. In this background present
study was conducted to assess the treatment outcome of
different category retreatment cases with the aim of finding
out the important predictors of unfavorable outcomes.
2. Methodology
This prospective cohort study was conducted in three tuber-
culosis units (TUs) of west Midnapore (a district of Eastern
India), covering mostly the tribal populated areas. Those
3 TUs were Hijli, Digri, and Sabang.West Midnapore is a dis-
trict of Eastern India where 14.87% of population are belong-
ing to tribal family and aremaintaining their tribal culture. In
this rural district tuberculosis treatment services are provided
from 11 TUs, 52 district microscopy centres, 119 peripheral
health institutes, 25 sputum collection centres, and 945 DOT
centers. We purposively selected 25% of TUs (3 TUs) where
tribal inhabitants are more.
All the tribal people who were registered for Category II
antituberculosis treatment between 1st quarter of 2013 (Jan to
Mar) to 4th quarter of 2013 (Oct to Dec) were considered as
our study cohort.They were followed up until their treatment
was completed as per DOTS guideline that is December
2014. Patients, who had incomplete follow-up data in register
and who were transferred out during the treatment, were
excluded from the study. All the data related to exposure and
outcomes were collected from tuberculosis unit’s register and
their follow-up data were also tracked from same secondary
data source.
Complete enumeration method was adopted here. In the
year of 2013, 478 retreatment cases were registered in those
3 TUs. Among them 37% (177) cases were belonging to tribal
population. Tribal population were identified, by observing
the surname lists under the tribal caste with clarification
from theGeneral Administration, as andwhennecessary.The
study was started with these 177 patients but ultimately ended
with 165 patients, because 9 patients were excluded due to
incompletion of data and 3 were transferred out during the
treatment (Figure 1).
3. Operational Definitions according to
RNTCP Guideline [7]
3.1. Category of Patients Present among Retreatment Case
Cohort. Relapse. It includes a TB patient who was declared
cured or completed treatment by a physician andwho reports
back to the health facility and is now found to be sputum
smear positive. Treatment after default. It includes a patient
who has received treatment for TB for a month or more from
any source and returns for treatment after having defaulted,
that is, not taking anti-TBdrugs consecutively for twomonths
or more and found to be smear positive. Treatment failure. It
includes any TB patient who is smear positive at 5 months or
more after initiation of treatment. Others. It includes patient
who does not fit into the any of the types mentioned above.
The reasons for labeling a patient under this type must be
specified in the Treatment Card and TB Register.
3.2. Treatment Outcome
(i) Favourable Outcome. Cured: it includes initially spu-
tum smear positive patient who has completed treat-
ment and had negative sputum smears on two occa-
sions, one of which was at the end of the treatment.
Treatment completed: it includes initially sputum
smear positive patient who has completed treatment
with negative smears at end of the intensive phase/two
months in the continuation phase, but none at the end
of the treatment is declared as treatment completed
or initially sputum smear negative patient who has
received full course of treatment and has not become
smear positive at the end of the treatment.
(ii) Unfavourable Outcome. Died: it includes patient who
died during the course of treatment regardless of any
cause. Failure: it includes any TB patient who is smear
positive at five months or more after initiation of
the treatment and not put on MDR-TB treatment.
Defaulted: it includes a patient after treatment initi-
ation has interrupted treatment consecutively for >2
months.
Patients were categorized according to following variables
like age, gender, address, religion, type of Category II patient
(relapse, failure, and treatment after default), and level of spu-
tum positivity. These variables were considered as exposure
characteristics.
Statistical analysis: data were entered in Microsoft Excel
worksheet (Microsoft, Redwoods, WA, USA) and were ana-
lyzed using IBM SPSS software, version 19.0 (Statistical
Package for the Social Sciences Inc., Chicago, IL, USA) and
Microsoft Excel. Chi-square test was performed for bivariate
analysis. Variables which were found statistically significant
(𝑃 = 0.05) in bivariate analysis were considered for
logistic regressionmodel and adjusted odd ratio was assessed
for predictor variables. Relative risk and attributed risk
were also assessed for significant predictors of unfavourable
outcome.




Depending on exposure characteristics
Exposed gr. versus nonexposed gr.
(external comparison),
for example, sputum positivity after
completion of initiation 
phase (sputum positive versus 
sputum negative)
Multiple comparison groups (internal comparison),
for example, sputum positivity pretreatment phase of
Ultimately study ended with 165 patients and treatment outcomes of 
retreatment cases were assessed. [December 2014]
Or
category II patients (scanty, 1+, 2+, 3+)
Total number of retreatment cases in Hijli, Digri, and Sabang TU between 
1st quarter of 2013 (Jan to Mar) to 4th quarter of 2013 (Oct to Dec)
N = 478
Total number of tribal population among 
the retreatment cases
N = 177 (37%)
9 were lost to follow-up due
to presence of incomplete data
and 3 were transferred out
Figure 1: Schematic diagram showing the study design.
4. Result
4.1. Baseline Characteristics of the Cohort. Among 165 tribal
patients, 53.9%were belonging to adolescent and young adult
group, 84.2% were male, 81.8% were Hindu, and 69.7% were
residing at rural community. Most of the cases of Category
II patients were relapsed case (33.9%) and 29.7% of the cases
were defaulter after preliminary treatment. In pretreatment
period, most of the cases (31.5%) were 2+ sputum positive.
After receiving initiation phase of Category II treatment
9.7% remained sputum positive. Unfavorable outcome was
observed among 24.8% patients. Among them mostly 51.2%
were defaulter, 22% were failure case, and 26.8% of patients
died during treatment.
4.2. Bivariate Analysis. As all the variables (exposure char-
acteristics) were qualitative in nature, chi-square test/Fisher
exact test were applied to find out the association with
treatment outcomes. The associations of unfavorable out-
comes were found significantly more among adolescent and
young adult patients (73.2%), treatment after default category
patients (46.3%), patients who were 2+ & 3+ sputum positive
at pretreatment phase (39% + 31.7% = 70.7%) and who were
sputum positive after completion of initiation phase (75.6%).
The chances of unfavorable outcomes were observed signifi-
cantly more among minority by religion patients in compar-
ison to favorable outcomes (34.1% versus 12.9%) (Table 1).
Among all types of unfavorable outcomes, defaulters
were found as most common treatment outcome (51.2%).
Defaulted treatment outcomes were observed mostly among
adolescent and young adult patients (53.3%),minority by reli-
gion (71.5%), and treatment after default Category II patients
(52.6%). After completion of initiation phase 50% of the
sputum positive patients completed their treatment period as
failure cases. About half (46.1%) of the pretreatment phase
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Table 1: Bivariate analysis between patient’s profile and treatment outcome.𝑁 = 165.









Adult (11–40) 59 (47.6) 30 (73.2)
Middle age (41–60) 59 (47.6) 8 (19.5)
Geriatric > 60 6 (4.8) 3 (7.3)
Gender
Male 104 (83.9) 35 (85.4) 𝜒2 = 0.052
df = 1
𝑃 = 0.82Female 20 (16.1) 6 (14.6)
Address
Rural 86 (69.4) 29 (70.7) 𝜒2 = 0.028
df = 1
𝑃 = 0.868Urban 38 (30.6) 12 (29.3)
Religion
Hindu 108 (87.1) 27 (65.9) 𝜒2 = 9.838
df = 2
𝑃 = 0.007
∗Minority by religion 16 (12.9) 14 (34.1)
Type of category II patients







Failure 6 (4.8) 5 (12.2)
Relapse 43 (34.7) 13 (31.7)
Transferred in 35 (28.2) 2 (4.9)











1+ 27 (21.8) 9 (22)
2+ 36 (29) 16 (39)




Negative 118 (95.2) 31 (75.6) Fisher exact test 𝑃
value = 0.001∗Positive 6 (4.8) 10 (24.4)
∗
𝑃 value is significant (<0.05).
(3+) sputum positive patients died during Category II treat-
ment phase (Table 2).
4.3. Logistic Regression. Factors which were found statisti-
cally significant in bivariate analysis were considered for
logistic regression to measures the relationship between the
categorical dependent variable (unfavorable outcome) and
one or more independent variables. The logistic regression
model was significant, as evident from omnibus chi-square
test (𝑃 = 0.00). All the independent variables together can
explain between 21.7% and 32.1% variance of the dependent
variable (unfavorable outcome), as evident from Cox & Snell
and Nagelkerke 𝑅 square. Regression model can correctly
predict 91.9% of favorable outcome and 36.6% of unfavorable
outcome. Overall, the model predicts 78.2% of the outcome
correctly, as shown by classification table. Ultimately in
logistic regressionmodel, religion and sputum positivity after
completion of initiation phase were predicted as the signif-
icant variable of unfavorable outcome. Patients, who were
minority by religion, were found 4 times more vulnerable
for unfavorable outcome (Odd’s Ratio = 4.1 (95% Confidence
Interval = 1.6–10.8), 𝑃 = 0.004). Unfavorable outcome was
found 7 times more common among retreatment TB cases
who remain sputum positive after completion of initiation
phase of Category II treatment (Odd’s Ratio = 6.9 (95%
Confidence Interval = 1.9–24.7), 𝑃 = 0.003) (Table 3).
4.4. Relative Risk and Attributed Risk. Relative risk and
attributed risk were calculated for the significant predictors.
Relative risk showed that patients, who were sputum positive
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Table 2: Distribution of tribal patients according to the patient’s profile and treatment outcome.𝑁 = 165.
Favourable outcome Total Unfavourable outcome Total
Cured Treatment completed Failure Defaulted Died
Age
Adolescent & young adult (11–40) 41 (69.49) 18 (30.51) 59 (100) 6 (20) 16 (53.3) 8 (26.7) 30 (100)
Middle age (41–60) 38 (64.4) 21 (35.6) 59 (100) 2 (25) 3 (37.5) 3 (37.5) 8 (100)
Geriatric > 60 3 (50) 3 (50) 6 (100) 1 (33.3) 2 (66.7) 0 (0) 3 (100)
Gender
Male 71 (68.3) 33 (31.7) 104 (100) 8 (22.9) 17 (48.5) 10 (28.6) 35 (100)
Female 11 (55) 9 (45) 20 (100) 1 (16.7) 4 (66.6) 1 (16.7) 6 (100)
Address
Rural 55 (64) 31 (36) 86 (100) 7 (24.1) 16 (55.2) 6 (20.7) 29 (100)
Urban 27 (71.1) 11 (28.9) 38 (100) 2 (16.6) 5 (41.7) 5 (41.7) 12 (100)
Religion
Hindu 68 (63) 40 (37) 108 (100) 8 (29.6) 11 (40.6) 8 (29.6) 27 (100)
Minority by religion 14 (87.5) 2 (12.5) 16 (100) 1 (7.1) 10 (71.5) 3 (21.4) 14 (100)
Types of category II patient
Treatment after default 29 (96.7) 1 (3.3) 30 (100) 3 (15.8) 10 (52.6) 6 (31.6) 19 (100)
Failure 6 (100) 0 (0) 6 (100) 3 (60) 2 (40) 0 (0) 5 (100)
Relapse 36 (83.7) 7 (16.3) 43 (100) 2 (15.4) 7 (53.8) 4 (30.8) 13 (100)
Others 8 (80) 2 (20) 10 (100) 1 (50) 1 (50) 0 (0) 2 (100)
Transferred in 3 (8.6) 32 (91.4) 35 (100) 0 (0) 1 (50) 1 (50) 2 (100)
Sputum positivity pretreatment phase
of category II patients
Scanty 10 (21.3) 37 (78.7) 47 (100) 1 (33.3) 1 (33.3) 1 (33.3) 3 (100)
1+ 25 (92.6) 2 (7.4) 27 (100) 1 (11.1) 6 (66.7) 2 (22.2) 9 (100)
2+ 33 (91.7) 3 (8.3) 36 (100) 4 (25) 10 (62.5) 2 (12.5) 16 (100)
3+ 14 (100) 0 (0) 14 (100) 3 (23.1) 4 (30.8) 6 (46.1) 13 (100)
Sputum positivity after completion of
initiation phase
Negative 77 (65.3) 41 (34.7) 118 (100) 4 (12.9) 19 (61.3) 8 (25.8) 31 (100)
Positive 5 (83.3) 1 (16.7) 6 (100) 5 (50) 2 (20) 3 (30) 10 (100)
after completion of initiation phase, had 2.98 times more risk
than others for the development of unfavorable outcome. In
case ofminority by religion that risk was 2.35 timesmore than
Hindu tribal. Attributed risk indicated that 66.4% of unfavor-
able outcome occurred due to failure of sputum conversion
after initiation phase of treatment. Religion of retreatment
cases attributed 57.4% cases of unfavorable outcome when
they were belonging to minority by religion (Table 4).
5. Discussion
This prospective cohort study was conducted during 2013
to 2014 and it was started with the tribal retreatment case
cohort who were registered as Category II tuberculosis cases
between 1st quarter of 2013 (Jan to Mar) and 4th quarter of
2013 (Oct to Dec) in three tuberculosis units (TUs) of west
Midnapore (a district of Eastern India) and ended onDecem-
ber 2014. The main reasons behind the unfavorable out-
comes of retreatment cases are irregular DOTS therapy, poor
coverage of RNTCP programme, quality of drugs, and health
care. Tribal inhabitants usually lived in hard to reach areas
where RNTCP coverage is poor and treatment outcome of
Category II cases is also unsatisfactory [8]. So the present
study was conducted on this special group of people to assess
the treatment outcome of different category retreatment cases
with the aim of finding out the important predictors of
unfavorable outcomes.
In the present study we have found 75.2% favourable
outcome that is similar to the treatment success rate (71%) of
India in retreatment TB cases [9]. Among the unfavourable
outcomes more were defaulter (51.2%) that also collaborate
with the Vijay et al. (72.8%) and Vasudevan et al. (37.6%)
study, but in our study, rate of defaulters was quite less than
Vijay et al. study and quite higher than Vasudevan et al.
study [10, 11]. Though the rate of defaulters was varied widely
within India but in all studies it was counted asmost common
unfavourable outcome. More numbers of defaulters indicate
the failure of programme implementation like poor coverage
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Table 3: Logistic regression model for the predictors of unfavourable outcome.
(a) Omnibus tests of model coefficients
Chi-square df Sig.
Step 1
Step 40.272 8 .000
Block 40.272 8 .000
Model 40.272 8 .000
(b) Model summary
Step −2 log likelihood Cox & Snell 𝑅 square Nagelkerke 𝑅 square
1 144.747a .217 .321







Outcome Favorable (0.00) 114 10 91.9
Unfavorable (1.00) 26 15 36.6
Overall percentage 78.2
aThe cut value is .500.
(d) Variables in the equation
𝐵 SE Wald df Sig. Exp(𝐵) 95% CI for EXP(𝐵)
Lower Upper
Step 1a
(1) Age −.014 .016 .723 1 .395 .986 .955 1.018
(2) Religion 1.415 .493 8.226 1 .004 4.115 1.565 10.821
(3) Type of category II patients 6.099 4 .192
Treatment after default (1) 1.416 .896 2.494 1 .114 4.120 .711 23.876
Failure (2) .985 1.080 .831 1 .362 2.678 .322 22.241
Relapse (3) .671 .898 .558 1 .455 1.955 .336 11.367
Transferred in & others (4) −.529 1.226 .186 1 .666 .589 .053 6.515
(4) Sputum positivity pretreatment phase of category II patients .358 .250 2.042 1 .153 1.430 .876 2.336
(5) Sputum positivity after completion of initiation phase 1.937 .649 8.920 1 .003 6.940 1.946 24.746
Constant −4.402 1.359 10.491 1 .001 .012
aVariable(s) entered on step 1: age, religion, type of category II patients, sputum positivity pretreatment phase of category II patients, and sputum positivity
after completion of initiation phase.
#Scoring:
Religion: Hindu = 0, minority by religion = 1; type of category II patients: treatment after default = 0, failure = 1, relapse = 2, and transferred in & others = 3;
sputum positivity pretreatment phase of category II patients: (scanty & 1+) = 0, (2+ & 3+) = 1; sputum positivity after completion of initiation phase: negative
= 0, positive = 1.
Table 4: Relative risk and attributed risk for significant predictors of unfavorable outcome.
Predictors of unfavorable outcome Relative risk Attributed risk (%)
Religion 2.35 57.4
Sputum positivity after completion of initiation phase 2.98 66.4
and lack of tracking activity of defaulters under the RNTCP.
In the present study, unfavorable outcomes were found sig-
nificantly more among adolescent and young adult patients
(73.2%), minority by religion (26.8%), and treatment after
default category patients (46.3%) and patients who were 2+
& 3+ sputum positive at pretreatment phase and who were
sputum positive after completion of initiation phase. Vijay et
al. study found treatment after default category patients as
potential defaulters/unfavourable outcome that is also sup-
ported by our study findings. Both Vijay et al. and Dandekar
et al. study found gender as significant predictors of overall
unfavourable treatment outcome, but we did not find any
significant relationship between gender and unfavourable
treatment outcome [10, 12]. We observed unfavourable out-
come commonly among high grade sputum positive patients
that is also collaborative with the Mukherjee et al. study
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observations. They also found unfavourable outcome most
likely among treatment failure subgroup but we observed it
more among treatment after default category patients (46.3%)
[13].
Ultimately logistic regression model found that patients,
who were minority by religion, were 4 times more vulnerable
for unfavorable outcome (Odd’s Ratio = 4.1 (95% Confidence
Interval = 1.6–10.8), 𝑃 = 0.004) and unfavorable outcomes
were also found to be 7 times more common among retreat-
ment TB cases who remain sputum positive after completion
of initiation phase of Category II treatment (Odd’s Ratio =
6.9 (95% Confidence Interval = 1.9–24.7), 𝑃 = 0.003). This
regression model can predict only 36.6% of unfavorable
outcome correctly. Programmatic variables were not assessed
in our study that can explain the low predictability of regres-
sion model. In spite of poor predicted ability of the regres-
sion model, it predicted two most important predictors of
unfavourable outcome that should be intervened to improve
the treatment outcome of retreatment TB cases.
In our study patients who were minority by religion were
more susceptible to unfavourable outcomes, but Dandekar
found no significant relationship between them and no such
observation was found in other studies also. It is more hard
for patients who are minority among tribals to reach group
due to their cultural and communication barrier. That might
explain their unfavorable outcomes. Sputum conversion rate
in our study was 90.3% and that is quite higher than
Vasudevan et al. study’s observation (76.9%). Patients who
remain sputum positive after completion of initiation phase
of Category II treatment were found more susceptible to
unfavourable outcome (OR = 6.9) that is also suggested by
Dooley et al. study (OR = 7.14) in Morocco [14]. In our study,
although there was no such scope to measure drug sensitivity
and resistance, it could be assume that more unfavourable
outcome among unsuccessful sputum converted cases prob-
ably due to development of drug resistance. It might be single
drug or multidrug resistance. If the MDR-TB diagnostics
resources facility scaled up everywhere then the problem
could be figure out more elaborately and results would be
more evidence based.
Though the present study was not any comparison
between tribal and nontribal population, its outcome was
found more or less same as overall treatment outcome.
Although poor living conditions, malnutrition, erroneous
health assumptions and beliefs concerning TB, lack of
resources, and treatment by traditional healers increase the
burden of TB among the tribal/indigenous population [15–
17], the treatment outcome is not significantly associated with
ethnicity that was also observed in a previous study con-
ducted by Chakrabarti et al. in West Bengal [18]. It indirectly
indicates that programme failure related variables like lack of
access to proper treatment, traditional and cultural barriers,
lack of tracking of defaulters, and so forth, which were not
addressed in previous study and were more important pre-
dictors than sociodemographic characteristics and it was felt
by Chakrabarti et al. also [18]. That means unfavourable out-
come among tribal population can be avoided, because it less
depends on nonmodifiable factors like ethnicity.
6. Conclusion
This study was conducted among tribal population in
assumption that unfavourable outcome will be found more
prevalent among them. But the study results collaborated
with the overall treatment outcome of India. In the end
of the study patients who were minority by religion and
who remained sputum positive after completion of initiation
phase of treatment were found more susceptible to unfa-
vourable outcome. Programmatic approach should be spec-
ified to address the minority by religion population by
breaking the communication barrier. Tracking of defaulters
and early diagnosis of drug resistance cases by scaling up
diagnostic facilities can reduce the load of sputum positive
cases after completion of initiation phase treatment as well as
unfavourable outcome also. In future studies if the pro-
gramme related variables could be addressed, more impor-
tant predictors of retreatment cases outcome will be revealed.
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